KR20210081915A - 포도당 검출을 위한 바이오센서의 전극 및 이의 제조방법 - Google Patents
포도당 검출을 위한 바이오센서의 전극 및 이의 제조방법 Download PDFInfo
- Publication number
- KR20210081915A KR20210081915A KR1020190174334A KR20190174334A KR20210081915A KR 20210081915 A KR20210081915 A KR 20210081915A KR 1020190174334 A KR1020190174334 A KR 1020190174334A KR 20190174334 A KR20190174334 A KR 20190174334A KR 20210081915 A KR20210081915 A KR 20210081915A
- Authority
- KR
- South Korea
- Prior art keywords
- electrode
- glucose
- copper
- nfs
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 87
- 239000008103 glucose Substances 0.000 title claims abstract description 87
- 238000001514 detection method Methods 0.000 title claims abstract description 44
- 238000000034 method Methods 0.000 title claims abstract description 32
- 239000002121 nanofiber Substances 0.000 claims abstract description 64
- 102000004190 Enzymes Human genes 0.000 claims abstract description 42
- 108090000790 Enzymes Proteins 0.000 claims abstract description 42
- 239000002105 nanoparticle Substances 0.000 claims abstract description 36
- 239000002082 metal nanoparticle Substances 0.000 claims abstract description 29
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 229940088598 enzyme Drugs 0.000 claims description 41
- 239000010931 gold Substances 0.000 claims description 31
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 26
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 24
- 229910052751 metal Inorganic materials 0.000 claims description 20
- 239000002184 metal Substances 0.000 claims description 20
- 108010015776 Glucose oxidase Proteins 0.000 claims description 19
- 239000004366 Glucose oxidase Substances 0.000 claims description 19
- 229940116332 glucose oxidase Drugs 0.000 claims description 19
- 235000019420 glucose oxidase Nutrition 0.000 claims description 19
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 15
- 229910021389 graphene Inorganic materials 0.000 claims description 14
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 13
- 229910052737 gold Inorganic materials 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 13
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 12
- 238000001523 electrospinning Methods 0.000 claims description 12
- 239000004020 conductor Substances 0.000 claims description 11
- 239000010949 copper Substances 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 8
- 229910052697 platinum Inorganic materials 0.000 claims description 8
- 102000003992 Peroxidases Human genes 0.000 claims description 7
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 7
- 229910052709 silver Inorganic materials 0.000 claims description 7
- 239000004332 silver Substances 0.000 claims description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 5
- 238000000576 coating method Methods 0.000 claims description 5
- 229910052802 copper Inorganic materials 0.000 claims description 5
- 108010046301 glucose peroxidase Proteins 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 229910052763 palladium Inorganic materials 0.000 claims description 4
- 239000004697 Polyetherimide Substances 0.000 claims description 3
- 239000002202 Polyethylene glycol Substances 0.000 claims description 3
- 229920001601 polyetherimide Polymers 0.000 claims description 3
- 229920001223 polyethylene glycol Polymers 0.000 claims description 3
- 229920000915 polyvinyl chloride Polymers 0.000 claims description 3
- 239000004800 polyvinyl chloride Substances 0.000 claims description 3
- 238000000151 deposition Methods 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 abstract description 8
- 239000010839 body fluid Substances 0.000 abstract description 8
- 230000035945 sensitivity Effects 0.000 abstract description 8
- 229960001031 glucose Drugs 0.000 description 76
- 239000002057 nanoflower Substances 0.000 description 55
- 239000000243 solution Substances 0.000 description 21
- 230000000694 effects Effects 0.000 description 10
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 5
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000002086 nanomaterial Substances 0.000 description 5
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- RAOSIAYCXKBGFE-UHFFFAOYSA-K [Cu+3].[O-]P([O-])([O-])=O Chemical compound [Cu+3].[O-]P([O-])([O-])=O RAOSIAYCXKBGFE-UHFFFAOYSA-K 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 229940098773 bovine serum albumin Drugs 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- -1 poly(vinyl alcohol) Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 235000002639 sodium chloride Nutrition 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 2
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000002441 X-ray diffraction Methods 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000000349 field-emission scanning electron micrograph Methods 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 229910000510 noble metal Inorganic materials 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 229920003169 water-soluble polymer Polymers 0.000 description 2
- CIWBSHSKHKDKBQ-SZSCBOSDSA-N 2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one Chemical compound OC[C@H](O)C1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-SZSCBOSDSA-N 0.000 description 1
- OGMADIBCHLQMIP-UHFFFAOYSA-N 2-aminoethanethiol;hydron;chloride Chemical compound Cl.NCCS OGMADIBCHLQMIP-UHFFFAOYSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- CZMRCDWAGMRECN-FBXJDJJESA-N D-sucrose Chemical compound O[C@@H]1[C@@H](O)[C@H](CO)O[C@]1(CO)O[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](CO)O1 CZMRCDWAGMRECN-FBXJDJJESA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- 229920000557 Nafion® Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- 238000001237 Raman spectrum Methods 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- KZNMRPQBBZBTSW-UHFFFAOYSA-N [Au]=O Chemical class [Au]=O KZNMRPQBBZBTSW-UHFFFAOYSA-N 0.000 description 1
- 238000004847 absorption spectroscopy Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 150000001408 amides Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000000970 chrono-amperometry Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000002484 cyclic voltammetry Methods 0.000 description 1
- 229940097265 cysteamine hydrochloride Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000005595 deprotonation Effects 0.000 description 1
- 238000010537 deprotonation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000000840 electrochemical analysis Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000003487 electrochemical reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002118 epoxides Chemical group 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 229910001922 gold oxide Inorganic materials 0.000 description 1
- ZFGJFDFUALJZFF-UHFFFAOYSA-K gold(3+);trichloride;trihydrate Chemical compound O.O.O.Cl[Au](Cl)Cl ZFGJFDFUALJZFF-UHFFFAOYSA-K 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940072417 peroxidase Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 238000001075 voltammogram Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3271—Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
- G01N27/3278—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction involving nanosized elements, e.g. nanogaps or nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Urology & Nephrology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Nanotechnology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
도 2는 구리-나노플라워@AuNPs-GO NF 기반으로 하는 전기화학 센서를 이용한 체액 내 포도당 검출 방법이다.
도 3은 구리-나노플라워@AuNPs-GO NF 기반으로 하는 전기화학 포도당 검출용 전극의 제조 흐름도이다.
도 4는 GO NF의 특성분석에 대한 그래프 및 이미지이다; (a)는 다양한 GO 농도 (0 ~ 2.0 mg/mL)에 대한 PVA NF의 전기화학 임피던스 값이다. (b)는 GO NFs 및 PVA NFs의 FT-IR 분광분석 결과이다. 소성된 GO NFs 의 특성으로, 소성 (c) 전/(d) 후의 FE-SEM 이미지이다.
도 5는 다양한 반응 시간에 대한 AuNPs-GO NF의 FE-SEM 이미지이다; 반응 시간은 (a) 10분, (b) 30분, (c) 60분, (d) 90분, (e) 120분 및 (f) 150분이다.
도 6은 다양한 GOx 농도에서 구리-나노플라워의 최적 조건을 확인한 이미지이다; GOx 농도는 (a) 0.3 mg/mL, (b) 0.5 mg/mL, (c) 0.7 mg/mL 및 (d) 1.0 mg/mL이다. 각 나노플라워는 GOx 농도를 제외하고는, 동일한 조건에서 합성되었다 (Cu2+ 이온 및 HRP의 농도는 각각 120 mM 및 0.05 mg/mL임).
도 7은 구리-나노플라워@AuNPs-GO NFs의 포도당 검출 조건을 확인한 그래프이다; (a)는 20 mV/s의 검출 속도, 30 μM 의 포도당 조건에서 측정된 GO NFs, Cu-나노플라워, Cu-나노플라워@GO NF 및 구리-나노플라워@AuNPs-GO NF 전극에 대한 순환 전압 전류 곡선이다. 구리-나노플라워@AuNPs-GO NF에 대한 작동 전극의 최적화 결과로, (b) 구리-나노플라워의 다양한 농도 (0 ~ 60 μg/mL) 또는 (c) 다양한 pH (pH 5 ~ 9) 환경에서 50 μM의 포도당 내 효소 전극의 전류를 측정하였다.
도 8은 구리-나노플라워@AuNPs-GO NFs의 포도당 검출 성능을 확인한 그래프이다; (a)는 다양한 포도당 농도 (0 ~ 0.1 mM)에서의 CV 전류 측정값이고, (b)는 검정 곡선(calibration curve)이다. (c) 50 μM의 포도당 및 다양한 방해제(interference)에 대한 구리-나노플라워@AuNPs-GO NF의 의존적 전류 반응이다. (d)는 안정성 시험을 위해 20일 동안 측정된 상대적 활성 값이다.
20: 나노섬유
30: 금속 나노입자
40: 효소 나노입자 복합체
100: 바이오센서 전극
Claims (13)
- 금속칩, 나노섬유, 금속 나노입자 및 효소 나노입자 복합체가 순차적으로 적층된 포도당 검출용 전극.
- 청구항 1에 있어서,
상기 금속칩은 백금(Pt), 금(Au), 은(Ag) 및 팔라듐(Pd)으로 이루어진 군에서 선택된 1종 이상인 것인, 전극.
- 청구항 1에 있어서,
상기 나노섬유는 전도성 물질 및 폴리머를 1:1 ~ 30의 중량비로 포함하는 것인, 전극.
- 청구항 3에 있어서,
상기 전도성 물질은 그래핀 산화물 및/또는 이온성 물질인 것인, 전극.
- 청구항 3에 있어서,
상기 폴리머는 폴리염화비닐, 폴리비닐알코올, 폴리에테르이미드 및 폴리에틸렌글라이콜로 이루어진 군에서 선택된 1종 이상인 것인, 전극.
- 청구항 1에 있어서,
상기 금속 나노입자는 백금(Pt), 금(Au), 은(Ag) 및 구리(Cu)로 이루어진 군에서 선택된 1종 이상인 것인, 전극.
- 청구항 1에 있어서,
상기 금속 나노입자는 나노섬유 표면에 정전기적 인력 또는 공유결합으로 결합되는 것인, 전극.
- 청구항 1에 있어서,
상기 효소 나노입자 복합체는 포도당 산화효소 및/또는 페록시다아제를 포함하는 것인, 전극.
- 청구항 1의 포도당 검출용 전극을 포함하는 포도당 검출 센서.
- a) 금속칩 상에 전기방사를 이용하여 나노섬유를 형성하는 단계;
b) 상기 나노섬유 상에 금속 나노입자를 코팅하는 단계; 및
c) 상기 금속 나노입자 상에 효소 나노입자 복합체를 점적하는 단계
를 포함하는 포도당 검출용 전극의 제조방법.
- 청구항 10에 있어서,
상기 a) 단계의 금속칩은 백금(Pt), 금(Au), 은(Ag) 및 팔라듐(Pd)으로 이루어진 군에서 선택된 1종 이상인 것인, 방법.
- 청구항 10에 있어서,
상기 a) 단계의 나노섬유는 전도성 물질 및 폴리머의 혼합 비율이 1:1 ~ 30의 중량비인 것인, 방법.
- 청구항 10에 있어서,
상기 c) 단계의 효소 나노입자 복합체는 포도당 산화효소 및/또는 페록시다아제를 포함하는 것인, 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190174334A KR102337896B1 (ko) | 2019-12-24 | 2019-12-24 | 포도당 검출을 위한 바이오센서의 전극 및 이의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190174334A KR102337896B1 (ko) | 2019-12-24 | 2019-12-24 | 포도당 검출을 위한 바이오센서의 전극 및 이의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210081915A true KR20210081915A (ko) | 2021-07-02 |
KR102337896B1 KR102337896B1 (ko) | 2021-12-09 |
Family
ID=76897370
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190174334A Active KR102337896B1 (ko) | 2019-12-24 | 2019-12-24 | 포도당 검출을 위한 바이오센서의 전극 및 이의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102337896B1 (ko) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113720820A (zh) * | 2021-09-03 | 2021-11-30 | 东北师范大学 | β-葡萄糖苷酶活性检测用免标记型光学纳米传感器及应用 |
CN114646605A (zh) * | 2022-03-26 | 2022-06-21 | 北京理工大学 | 一种金单原子葡萄糖氧化纳米酶的制备方法及应用 |
CN114755279A (zh) * | 2022-04-19 | 2022-07-15 | 桂林电子科技大学 | 基于GOX/RGO-CS-Fc/AuNPs/SiO2-Si单元检测葡萄糖的方法 |
CN115524295A (zh) * | 2022-10-09 | 2022-12-27 | 兰州大学 | 基于葡萄糖氧化酶的多模-无芯-多模光纤等离子体共振葡萄糖传感器 |
CN115611270A (zh) * | 2022-09-30 | 2023-01-17 | 武汉工程大学 | 一种氮掺杂多孔石墨烯负载铜氧化物电极材料及其制备方法和应用 |
WO2023027667A1 (en) * | 2021-08-25 | 2023-03-02 | Hi̇ti̇t Üni̇versi̇tesi̇ Rektörlüğü | A ceramic nanofiber based electrochemical glucose sensor to be used as a consumable in blood sugar measurement |
CN117629923A (zh) * | 2022-08-19 | 2024-03-01 | 南开大学 | 一种多信号输出的压力及抑郁症标志物定量测试方法及其应用 |
KR20240162883A (ko) | 2023-05-09 | 2024-11-18 | 상명대학교 천안산학협력단 | 땀에서의 대사물질 검출용 전기화학적 나노바이오센서 구조체 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110128606A (ko) * | 2010-05-24 | 2011-11-30 | 한국과학기술원 | 자성 나노입자-플래티늄 나노입자-다공성 탄소 복합체 및 그 제조방법 |
KR20130032507A (ko) * | 2011-09-23 | 2013-04-02 | 포항공과대학교 산학협력단 | 유기 금속을 포함하는 자기조립성 고분자를 포함하는 전극 및 그 제조 방법 |
KR20190024411A (ko) * | 2017-08-31 | 2019-03-08 | 건국대학교 산학협력단 | 금속나노튜브에 바이오물질을 고정하는 방법 및 이를 포함하는 바이오센서 |
-
2019
- 2019-12-24 KR KR1020190174334A patent/KR102337896B1/ko active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110128606A (ko) * | 2010-05-24 | 2011-11-30 | 한국과학기술원 | 자성 나노입자-플래티늄 나노입자-다공성 탄소 복합체 및 그 제조방법 |
KR20130032507A (ko) * | 2011-09-23 | 2013-04-02 | 포항공과대학교 산학협력단 | 유기 금속을 포함하는 자기조립성 고분자를 포함하는 전극 및 그 제조 방법 |
KR20190024411A (ko) * | 2017-08-31 | 2019-03-08 | 건국대학교 산학협력단 | 금속나노튜브에 바이오물질을 고정하는 방법 및 이를 포함하는 바이오센서 |
Non-Patent Citations (2)
Title |
---|
Polymer Letters, vol.8, pp.565-573 (2014) 1부.* * |
Sensors and Actuators B, vol.238, pp.392-401 (2017) 1부.* * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023027667A1 (en) * | 2021-08-25 | 2023-03-02 | Hi̇ti̇t Üni̇versi̇tesi̇ Rektörlüğü | A ceramic nanofiber based electrochemical glucose sensor to be used as a consumable in blood sugar measurement |
CN113720820A (zh) * | 2021-09-03 | 2021-11-30 | 东北师范大学 | β-葡萄糖苷酶活性检测用免标记型光学纳米传感器及应用 |
CN114646605A (zh) * | 2022-03-26 | 2022-06-21 | 北京理工大学 | 一种金单原子葡萄糖氧化纳米酶的制备方法及应用 |
CN114755279A (zh) * | 2022-04-19 | 2022-07-15 | 桂林电子科技大学 | 基于GOX/RGO-CS-Fc/AuNPs/SiO2-Si单元检测葡萄糖的方法 |
CN117629923A (zh) * | 2022-08-19 | 2024-03-01 | 南开大学 | 一种多信号输出的压力及抑郁症标志物定量测试方法及其应用 |
CN115611270A (zh) * | 2022-09-30 | 2023-01-17 | 武汉工程大学 | 一种氮掺杂多孔石墨烯负载铜氧化物电极材料及其制备方法和应用 |
CN115611270B (zh) * | 2022-09-30 | 2024-04-23 | 武汉工程大学 | 一种氮掺杂多孔石墨烯负载铜氧化物电极材料及其制备方法和应用 |
CN115524295A (zh) * | 2022-10-09 | 2022-12-27 | 兰州大学 | 基于葡萄糖氧化酶的多模-无芯-多模光纤等离子体共振葡萄糖传感器 |
KR20240162883A (ko) | 2023-05-09 | 2024-11-18 | 상명대학교 천안산학협력단 | 땀에서의 대사물질 검출용 전기화학적 나노바이오센서 구조체 |
Also Published As
Publication number | Publication date |
---|---|
KR102337896B1 (ko) | 2021-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102337896B1 (ko) | 포도당 검출을 위한 바이오센서의 전극 및 이의 제조방법 | |
Baek et al. | Cu-nanoflower decorated gold nanoparticles-graphene oxide nanofiber as electrochemical biosensor for glucose detection | |
Deshmukh et al. | Non-enzymatic electrochemical glucose sensors based on polyaniline/reduced-graphene-oxide nanocomposites functionalized with silver nanoparticles | |
Du et al. | Electrospun nanofiber-based glucose sensors for glucose detection | |
Zahed et al. | Silver nanoparticles decorated polyaniline nanocomposite based electrochemical sensor for the determination of anticancer drug 5-fluorouracil | |
Zhou et al. | A sensor of a polyoxometalate and Au–Pd alloy for simultaneously detection of dopamine and ascorbic acid | |
EP3488236B1 (en) | On-chip graphene electrode, methods of making, and methods of use | |
Elancheziyan et al. | Covalent immobilization and enhanced electrical wiring of hemoglobin using gold nanoparticles encapsulated PAMAM dendrimer for electrochemical sensing of hydrogen peroxide | |
Lin et al. | Electrochemical DNA sensor by the assembly of graphene and DNA-conjugated gold nanoparticles with silver enhancement strategy | |
US8715981B2 (en) | Electrochemical biosensor | |
Yang et al. | Hydrogen peroxide and glucose biosensor based on silver nanowires synthesized by polyol process | |
Babu et al. | Binder free and free-standing electrospun membrane architecture for sensitive and selective non-enzymatic glucose sensors | |
KR102423250B1 (ko) | 효소 기반의 전위차법 글루코스 검출용 센서 및 이의 제조방법 | |
Torkashvand et al. | Construction of a new electrochemical sensor based on molecular imprinting recognition sites on multiwall carbon nanotube surface for analysis of ceftazidime in real samples | |
Chen et al. | 3-mercaptopropylphosphonic acid modified gold electrode for electrochemical detection of dopamine | |
Chauhan et al. | Chitosan-based biosensors-A comprehensive Review | |
Narayanan et al. | Towards a dual in-line electrochemical biosensor for the determination of glucose and hydrogen peroxide | |
He et al. | CVD graphene incorporating polymerized l-cysteine as an electrochemical sensing platform for simultaneous determination of dopamine and ascorbic acid | |
Jain et al. | Synthesis of cadmium oxide and carbon nanotube based nanocomposites and their use as a sensing interface for xanthine detection | |
Dong et al. | Au nanoparticle/CoFc/metal–organic framework as enzyme-free dual-signal ratiometric electrochemical sensor for in-situ determination of cell-secreted H2O2 | |
Wang et al. | Multilayer sensing platform: gold nanoparticles/prussian blue decorated graphite paper for NADH and H 2 O 2 detection | |
He et al. | A selective sensing platform for the simultaneous detection of ascorbic acid, dopamine, and uric acid based on AuNPs/carboxylated COFs/Poly (fuchsin basic) film | |
Huang et al. | Controllable surface engineered three-dimensional porous graphene based electrode for ultrasensitive flexible electrochemical sensing | |
Sai-Anand et al. | One pot synthesis of new gold nanoparticles dispersed poly (2-aminophenyl boronic acid) composites for fabricating an affinity based electrochemical detection of glucose | |
Narang et al. | A third generation bilirubin sensor development by using gold nanomaterial as an immobilization matrix for signal amplification |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20191224 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20210507 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20211127 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20211206 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20211207 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20241007 Start annual number: 4 End annual number: 4 |